[HTML][HTML] Neuromyelitis optica spectrum disorders

S Huda, D Whittam, M Bhojak, J Chamberlain… - Clinical Medicine, 2019 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon antibody-mediated
disease of the central nervous system. Long segments of spinal cord inflammation (myelitis) …

Neuromyelitis spectrum disorders

BG Weinshenker, DM Wingerchuk - Mayo Clinic Proceedings, 2017 - Elsevier
The understanding of neuromyelitis optica spectrum disorder (NMOSD) has evolved
substantially since its initial description over a century ago. The discovery in 2004 of a …

[HTML][HTML] EU paediatric MOG consortium consensus: Part 1–Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated …

AL Bruijstens, C Lechner, L Flet-Berliac, K Deiva… - European Journal of …, 2020 - Elsevier
Over the past few years, increasing interest in the role of autoantibodies against myelin
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating …

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG–positive NMOSD

E Shosha, D Dubey, J Palace, I Nakashima, A Jacob… - Neurology, 2018 - AAN Enterprises
Objective To define the frequency, duration, and severity of intractable nausea, vomiting, or
hiccups in aquaporin-4–immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica …

Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?

H Stiebel-Kalish, MA Hellmann, M Mimouni… - Neurology …, 2019 - AAN Enterprises
Objective To investigate whether visual disability which is known to accumulate by poor
recovery from optic neuritis (ON) attacks can be lessened by early treatment, we investigated …

Difference in the source of anti-AQP4-IgG and anti-MOG-IgG antibodies in CSF in patients with neuromyelitis optica spectrum disorder

T Akaishi, T Takahashi, T Misu, K Kaneko, Y Takai… - Neurology, 2021 - AAN Enterprises
Objective To elucidate the differences in the source and in the level of intrathecal synthesis
between anti–aquaporin-4 antibodies (AQP4-IgG) and anti-myelin oligodendrocyte …

Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis

BG Dutra, AJ da Rocha, RH Nunes, ACM Maia - Radiographics, 2018 - pubs.rsna.org
Neuromyelitis optica (NMO) is an autoimmune demyelinating disorder for which the
aquaporin-4 (AQP4) water channels are the major target antigens. Advances in the …

Neuromyelitis optica spectrum disorder: patient experience and quality of life

J Beekman, A Keisler, O Pedraza… - Neurology …, 2019 - AAN Enterprises
Objective To gain insights into NMOSD disease impact, which may negatively affect QoL of
patients, their families, and social network. Methods The current study used validated …

Diagnosis and management of neuromyelitis optica spectrum disorders-An update

A Bruscolini, M Sacchetti, M La Cava, M Gharbiya… - Autoimmunity …, 2018 - Elsevier
Neuromyelitis optica (NMO) and Neuromyelitis optica spectrum disorders (NMOSD) are a
group of autoimmune conditions characterized by inflammatory involvement of the optic …

A comprehensive review of the advances in neuromyelitis optica spectrum disorder

P Siriratnam, S Huda, H Butzkueven… - Autoimmunity …, 2023 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing neuroinflammatory
autoimmune astrocytopathy, with a predilection for the optic nerves and spinal cord. Most …